Picture of Generation Bio logo

GBIO — Generation Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Generation Bio Co reports results for the quarter ended in June - Earnings Summary

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted loss
of 55 cents​​ per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 47 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Generation Bio Co's reported EPS for the quarter was a loss
of 55 cents​.
* The mean earnings estimate of analysts had risen by about 1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Generation Bio Co shares had fallen by 11.5% this quarter and
lost 16.0% so far this year.
* The company reported a quarterly loss of $30.79 million.
* Wall Street's median 12-month price target for Generation Bio
Co is $39.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 05:33 a.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Generation Bio

See all news